new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers

August 2009

You'll see new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers.

This is a surprise. We usually think of Singulair as benign.

But now some patients are reporting insomnia, agitation, anxiety, depression, and similar problems.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote